Priorities in 2013 will look a lot like last year's for the Medical Device Manufacturers Association, as the trade group maintains its focus on FDA implementation of the latest user fee agreement and repeal of the medical device excise tax.
MDMA Will Focus On FDA Performance, Device Tax Repeal In 2013
The Medical Device Manufacturers Association discusses its top priorities for the new year.
More from Strategy
More from Business
• By
Abbott presented late-breaking data at the 2025 American College of Cardiology conference demonstrating that TriClip transcatheter edge-to-edge repair offers prolonged patient benefits compared to medical treatment alone after two years, which were not evident at one year.
• By
The Cologuard Plus test has a sensitivity of 95% and a specificity of 94% for the detection of colorectal cancer; “unmatched accuracy,” according to Exact Sciences.